Table of Contents

Feature Articles

Select this article
- Lisa S. Rotenstein,
- Benjamin M. Kozak,
- Joseph P. Shivers,
- Mark Yarchoan,
- John Close,
- and Kelly L. Close
The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We?
Clinical Diabetes April 2012 30:44-53; doi:10.2337/diaclin.30.2.44
Select this article
- Pendar Farahani
A Perspective on Principles of Comparative Cost-Effectiveness Studies for Pharmacotherapy of Chronic Diseases
Clinical Diabetes April 2012 30:54-60; doi:10.2337/diaclin.30.2.54

Select this article
- Davida F. Kruger
Diabetes Treatment Options: One Size Does NOT Fit All
Clinical Diabetes April 2012 30:41-43; doi:10.2337/diaclin.30.2.41

Select this article
- Nathaniel G. Clark
Postprandial Blood Glucose, Cardiovascular Events, and All-Cause Mortality: How Do We Use Postprandial Glucose in Clinical Practice?
Clinical Diabetes April 2012 30:67-69; doi:10.2337/diaclin.30.2.67

Select this article
- John E. Brunner and
- Guillermo M. Guardia
A New Challenge for Safe Ordering of U-500 Insulin: Electronic Medicine Reconciliation
Clinical Diabetes April 2012 30:70-71; doi:10.2337/diaclin.30.2.70
Select this article
- Sharon W. Lahiri
Management of Type 2 Diabetes: What Is the Next Step After Metformin?
Clinical Diabetes April 2012 30:72-75; doi:10.2337/diaclin.30.2.72

Select this article
- Virginia Valentine
Don't Resist Using U-500 Insulin and Pramlintide for Severe Insulin Resistance
Clinical Diabetes April 2012 30:80-84; doi:10.2337/diaclin.30.2.80

Select this article

Using U-500 Insulin
Clinical Diabetes April 2012 30:86; doi:10.2337/diaclin.30.2.86